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Abstract
The objective of this study was to assess mother-
to-child transmission rates of HIV in Brazil dur-
ing the years 2000 and 2001, and to identify the 
maternal and neonatal variables that were as-
sociated with this transmission. It was a cross-
sectional, observational study with retrospective 
data obtained from patient medical records. 
The children were followed at 63 medical sites 
situated in five geographical macro-regions of 
the country (20 States and the Federal Capital). 
Children enrolled were those that were born of 
HIV-infected mothers and it was necessary for 
the mothers to present documented proof of 
HIV-infection before or during pregnancy, at 
time of delivery or in the first three months af-
ter delivery. There were 2,924 children enrolled 
and mother-to-child transmission rates of HIV 
were 8.6% (95%CI: 7.2-10.2) for the year 2000 
and 7.1% (95%CI: 5.8-8.6) for the year 2001. The 
following variables were associated with lower 
mother-to-child transmission rates of HIV: elec-
tive cesarean section, diagnosis of mother’s in-
fection before or during pregnancy, access to HIV 
viral load and T CD4+ lymphocyte count during 
prenatal care, greater birth weight and avoid-
ance of breastfeeding.
Vertical Disease Transmission; HIV; Prenatal 
Care
Introduction
As of June 2005 there had been 11,901 cases of 
AIDS in children under 13 years reported to the 
Brazilian National STD/AIDS Program (PNDST/
AIDS) of the Ministry of Health and vertical trans-
mission was responsible for 83.7% of these cases 1. 
Despite the undeniable reduction in recent years 
in the reporting of mother-to-child transmission 
of HIV: 1,002 cases in 1997 versus 390 in 2004 2, it 
is still not sufficiently clear how the recommenda-
tions from the PNDST/AIDS for the reduction of 
HIV vertical transmission are being applied and 
what are their impact in the various regions of the 
country. In Brazil, the AIDS incidence rate con-
tinues to be high (17.1 cases per 100,000 in 2004), 
basically due to its tendency for growth among 
the female population; there has been a decline 
among children of less than 5 years and in males, 
a reduction in AIDS rates among younger people 
from 13 to 29 years old, and an increase among 
older people, principally from 40 to 59 years old. 
Among women, since 1988, there has been a ten-
dency for stabilization among people aged 13 to 
24 years old, but with a persistent growth in prac-
tically all other age groups 1.
The reporting of seropositive pregnant 
women became compulsory in Brazil in 2000, 
and it has been increasing over the time period 
under analysis, but for the year 2004, of the es-
timated 12,644 seropositive pregnant women, 
only around 52% were reported 1.
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In 1994, with the publication of the findings 
of protocol PACTG 076 2, it became evident that 
a significant reduction in HIV transmission from 
infected mothers to their children was possible 
through AZT prophylaxis for pregnant mothers 
and newborns. The rates of vertical HIV transmis-
sion that had, in the absence of any intervention 
until 1994, varied from 12% to 42% 3, fell signifi-
cantly to rates of less than 2% in those countries 
that, in addition to this and other therapeutic 
regimens (combined regimens), implemented 
pre-natal HIV testing and counseling and avoid-
ance of breastfeeding 4,5,6,7.
Reducing vertical HIV transmission has been 
a goal of health programs in various parts of the 
world 8. In Brazil, the guarantee of availability 
of antiretroviral medication for all patients with 
therapeutic indications, the offer of anti-HIV 
testing during gestation, the possibility of moni-
toring viral load and CD4 lymphocyte count, and 
the access to special services, has had a great 
impact on the quality of life of those individu-
als infected with HIV and significantly reduced 
mother-to-child transmission of HIV 9,10,11,12. 
The access to the benefits of antiretroviral ther-
apy, however, still do not reach all seropositive 
pregnant women 13. Making available HIV diag-
nosis, and the prophylactic measures needed, to 
all pregnant women is a huge challenge in many 
regions of the country.
The objective of this study is to estimate HIV 
vertical transmission rates in Brazil in the years 
2000 and 2001, and the maternal and newborn 
variables associated with these rates in different 
regions of the country.
Material and methods
The necessity of obtaining data representative 
of the Brazilian vertical HIV transmission real-
ity motivated the Comitê de Doenças Infeccio-
sas, Sociedade Brasileira de Pediatria [Infeccious 
Disease Commitee, Brazilian Pediatrics Society] 
to organize a study group with representatives 
from various parts of the country. The choice of 
participating health services was made through 
contacts of the Brazilian Pediatrics Society with 
places that were known to attend the greatest 
number of cases in each region.
The Grupo de Estudo da Sociedade Brasileira 
de Pediatria para Avaliar a Transmissão Materno-
Infantil do HIV is a multicentric group created in 
2001 by the Chapter of Infectology of the Socie-
dade Brasileira de Pediatria, with the purpose of 
estimating the extent of HIV vertical transmis-
sion in Brazil. The group consists of profession-
als from all over the country who follow children 
born to mothers infected with HIV and partici-
pating services (in which these professionals are 
inserted and from where the data are collected), 
characterized by providing clinical and laborato-
rial follow up to these children.
To carry out this study, doctors from 63 health 
services located in the five macro regions of the 
country (twenty states and the Federal District) 
participated. The distribution of the services ac-
cording to geographic regions of the country was 
the following: 4 services in the  Northern Region 
– States of Amazonas, Pará, and Amapá; 8 in the 
Northeastern Region – States of Alagoas, Bahia, 
Ceará, Maranhão, Paraíba, Pernambuco, and Ser-
gipe; 4 in the Central Western Region – States of 
Goiás, Mato Grosso, and the Federal District; 39 
in the Southeastern Region – States of Espírito 
Santo, Minas Gerais, Rio de Janeiro, and São Pau-
lo; and 7 in the Southern Region – States of Rio 
Grande do Sul, Paraná, and Santa Catarina.
The participating medical services were clas-
sified into the following categories, according to 
their administrative structures: 1 basic health-
care provider (UBS), 19 university hospitals, 26 
specialized STD/AIDS clinics, 6 general hospi-
tals, and 11 others characterized as other medical 
services (private, mixed etc.). The necessity for 
specialized medical care for these children was 
probably what characterized the participating 
services, with the majority of them being either 
specialized in STD/AIDS, or university hospitals.
This study is a cross-sectional observational 
one, with retrospective data obtained from the 
medical records of the participating services. 
When possible, information was also collected 
from the medical records of the mothers of the 
children included in the research (when both 
mother and child were attended by the same ser-
vice). A databank was created for the collection 
of information obtained about the mother (age, 
time of HIV diagnosis, exposure category, prena-
tal care, antiretroviral therapy, mode of delivery, 
length of gestation) and the child (birth-weight, 
breastfeeding, HIV infection).
To define the population studied, the follow-
ing inclusion criteria were established: children 
born during the period from January 1, 2000 to 
December 31, 2001 whose mothers had a docu-
mented HIV infection before or during gesta-
tion, at the moment of admission for childbirth 
or in the first three months after childbirth. Only 
the mother-child pairs in whom it was possible 
to define the status of the infection of the child 
(infected or not infected) were included in the 
study. The inability to define the situation of the 
HIV infection by the end of the data collection 
period (June 2003) was considered a criterion 
for exclusion.
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Children were considered not infected if they 
presented no clinical symptoms of AIDS and test-
ed negative (or had no reaction to) for two of the 
following tests: test for HIV antibodies carried out 
after 6 months of life, or two quantifications of vi-
ral RNA with results below the detection level, at 
least one of them taken after the fourth month of 
life, or two negative tests of DNA through poly-
merase chain reaction (PCR) carried out after the 
second week of life.
Children considered infected were those who 
presented clinical symptoms indicating AIDS 
and/or presented positive/reagent results on two 
of the following tests, taken at different times: 
test for HIV antibodies carried out after the 15th 
month of life, or quantification of viral RNA with 
a result above detection level at least one of which 
was realized after the first month of life, or a posi-
tive PCR realized after the second week of life.
The definition of the HIV infection in children 
was slightly modified in relation to the Guia de 
Tratamento Clínico da Infecção pelo HIV em Cri-
anças (Guide for Treatment of the HIV Infection in 
Children), published by the Brazilian Ministry of 
Health 14 with the object of defining, with certain-
ty, and as early as possible, the infectious status of 
children, because in some regions of the country 
it is difficult to easily obtain exam results.
Prenatal care
For the purposes of this study, prenatal care was 
considered to be any number of medical or nurs-
ing consultations that women have during gesta-
tion. This definition was the result of interview-
ing a large number of women, who were asked 
to answer yes or no to the following question: did 
you have prenatal care?
“Transmitting mothers”, for the purposes of 
this study, were considered to be those whose 
children (included in the study) were defined as 
being infected with HIV. Non-transmitting moth-
ers were considered to be those whose children 
were defined as not being HIV-infected.
Use of antiretroviral therapy during 
gestation, during labor or for the newborn
For each woman studied it was possible to identify 
the moment that the use of antiretroviral therapy 
began (gestation, labor, post-labor), but some-
times the drugs used and their dosage were not 
well-defined. Information about the use of any 
antiretroviral therapy in any moment of gesta-
tion, during labor, or in the neonatal period even 
though it was not possible to identify the specific 
drugs used, their dosage, or length of treatment, 
was considered positive.
Any information about exams utilized in the 
monitoring of the HIV infection carried out dur-
ing gestation (exams quantifying the viral load of 
HIV and CD4+/CD8+ T lymphocyte count), even 
when their results or the time of their realization 
were not available in medical records, was de-
fined as access to prenatal HIV infection testing.
A record of any maternal breastfeeding at any 
time and for any duration was defined as “mater-
nal beastfeeding present”.
The transmission rate was expressed as a per-
centage with the respective confidence interval 
at 95% (95%CI). The categorical variables (time 
of HIV infection diagnosis, prenatal exams, use 
of antiretroviral therapy during gestation, type of 
birth, realization of exams during gestation) were 
expressed as a number and percentage, and the 
numerical values (age of mothers at childbirth) 
were expressed as an average ± standard devia-
tion.
In univariate analysis, the association be-
tween the transmission rate and each of the 
demographic and clinical variables used chi-
square tests, and in cases in which the frequency 
expected was less than five Fisher’s exact test. In 
multivariate analysis, logic regression was used 
to evaluate the association between the status of 
the child’s infection and the different characteris-
tics of the mothers and children.
In all the statistical analysis a significance 
level of 5% was adopted, in other words, results 
that presented a p value less than 5% (p < 0.05) 
were considered significant.
The study was approved by the Commission 
of Ethics in Research of the Universidade Federal 
de São Paulo [Federal University of São Paulo] 
and the representatives of each service signed an 
agreement, taking responsibility for the collec-
tion and confidentiality of the data. Services with 
local research ethics committees also obtained 
local approval.
Results
Among 3,421 mother-child pairs that began the 
follow-up in the participating heath care services 
only 2,924 (85.5%) were included for analysis. 
The reasons for non-inclusion of mother-child 
pairs were the following; abandonment and/or 
transfer to another health service (167 cases), 
death without confirmation of infectious status 
(13 cases), and undefined infectious status until 
the end of data collection period (317 cases). The 
HIV vertical transmission rate observed was 8.6% 
among children born in the year 2000 (95%CI: 
7.2-10.2) and 7.1% among children born in 2001 
(95%CI: 5.8-8.6) (Table 1). In the year 2000 the 
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transmission rate varied from 4.9% (Central-
Western Region) to 17.6% (Northern Region), 
but there were no significant differences in rates 
among the five regions. In 2001 the transmission 
rate varied from 4.4% (Central-Western Region) 
to 18.9% (Northern Region); the Southeastern, 
Southern, and Central-Western Regions had low-
er rates of transmission than the Northern and 
Northeastern Regions.
The characteristics of the mothers and chil-
dren according to year of children’s birth and HIV 
vertical transmission can be seen in Table 2.
The age of the mothers varied from 13 to 47 
years, the average age ± standard deviation be-
ing distributed in macro-regions in this way: 
27.9 ± 5.9 years in the Southeastern Region; 26.3 
± 5.8 years in the Southern Region; 25.5 ± 5.5 
years in the Central-Western Region; 26.8 ± 5.8 
years in the Northeastern Region; and 26.0 ± 6.5 
years in the Northern Region. The average age 
of mothers was higher in the Southeastern Re-
gion, but the average age in the five regions did 
not differ among the transmitting mothers and 
the non-transmitting mothers. Only 148/2,924 
(5.1%) of the mothers were 18 years or younger 
and 321/2,924 (11%) were 20 years or younger. 
When the group of mothers is stratified by age 
(≥ 30 years or < 30 years) there was no significant 
difference between transmission rates.
The diagnosis of the HIV infection was made 
before or during pregnancy in 1,242 women 
(89.3%) in the year 2000 and in 1,266 women 
(90.4%) in the year 2001. Women who had the 
diagnosis made before or during pregnancy pre-
sented lower vertical transmission (5.2% in 2000 
and 4.3% in 2001) than those whose diagnosis 
was made during labor or after birth (32.9% in 
2000 and 26.9% in 2001). In the Southeastern and 
Southern Regions there was a greater proportion 
of diagnoses made before or during gestation 
when compared with other regions; diagnoses 
made before or during pregnancy were associat-
ed with lower rates of HIV vertical transmission in 
the two years studied and in all the regions stud-
ied, with the exception of the Northern Region in 
2000 and the Central-Western Region in 2001.
Information about prenatal care was collect-
ed for 2,712 mothers. Among them 1,286/1,361 
(94.5%) in 2000 and 1,295/1,351 in 2001 received 
prenatal care. The Central-Western and Northern 
Regions were the ones where a greater propor-
tion of mothers received prenatal care. Lower 
rates of mother-to-child HIV transmission were 
associated with prenatal care in all regions ana-
lyzed during the two years studied, with the ex-
ception of the Northern Region in 2000 and the 
Southeastern and Northeastern Regions in 2001. 
Mother-to-child HIV transmission among wom-
en with/without prenatal care was 6.5%/28.7% in 
2000 and 5.6%/18% in 2001.
The use of antiretroviral therapy during preg-
nancy was observed in 2,305 women (1,143 in 
2000 and 1,162 in 2001), 81.4% and 82.5% respec-
tively for women with this information available. 
The Southeastern, Southern, and Central-West-
ern Regions presented the greatest proportion 
of antiretroviral therapy use during pregnancy 
(82.9%) compared to the Northeastern and 
Northern Regions (71.8%). The Northern Region 
had the least use of antiretroviral therapy dur-
ing gestation compared to the other regions. The 
vertical transmission rate was significantly lower 
among infants whose mothers had used anti-
retroviral therapy during pregnancy (81/2,305 = 
3.5%) compared to those without this interven-
tion (131/508 = 25.8%). The HIV vertical trans-
mission rate was of 4.2% and 2.8% respectively, in 
the two years studied, among mothers that had 
used antiretroviral therapy; mothers who had 
not used antiretroviral therapy had transmission 
Table 1 
Number of mother-child pairs included and infected children per year of birth and region of origin. Brazil, 2000-2001.
 Region Year 2000 Year 2001
  Mother-child pairs Infected children Mother-child pairs Infected children
  n n (%) n n (%)
 Southeast 914 84 (8.2) 874 61 (7.0)
 South 343 25 (7.3) 366 16 (4.4)
 Central-West 82 4 (4.9) 73 4 (5.5)
 Northeast 89 7 (7.9) 112 16 (14.3)
 North 34 6 (17.6) 37 7 (18.9)
 Total 1,462 126 (8.6) 1,462 104 (7.1)
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rates of 27.2% and 24.3% respectively, in the two 
years studied.
HIV transmission was significantly modified 
depending on the mode of delivery: in the two 
years evaluated caesarian section was found to 
be associated with lower rates of vertical trans-
mission. Vaginal delivery, which was realized in 
518/1,395 (37.1%) women in the year 2000 and 
in 536/1,411 (38%) in 2001, was found to be as-
sociated with higher vertical transmission in the 
Southeastern, Southern, and Northeastern Re-
gions in 2000, and the Southeastern Region in 
2001. The rate of vaginal delivery was lower in the 
Central-Western (25.6%), Southern (37.3%), and 
South eastern (35%) Regions than in the North-
ern (47.8%), and Northeastern (42.7%) Regions.
Access to exams for evaluating the HIV in-
fection status (quantification of viral load and T 
lymphocytes CD4+/CD8+ count) was obtained 
for 693/1,462 (47.4%) of the women in the year 
2000 and 766/1,462 (52.4%) in 2001. The access to 
these exams proved most frequent in the South-
eastern, Southern, and Central-Western Regions 
and was linked to lower vertical HIV transmission 
rates in the Southeastern and Southern Regions 
in the year 2000, and the Southeastern, Southern, 
and Northern Regions in 2001.
The gestational age was known in 1,702 chil-
dren evaluated and 16.6% of them were prema-
ture. Lower rates of vertical HIV transmission 
were found to be associated with full term gesta-
tion (5.8%) when compared to premature gesta-
Table 2  
Number and proportion (%) of infected children, according to the year of birth and selected characteristics of mothers and children. Brazil, 2000-2001.
    Year  2000   Year  2001
   Women  Children p * Women Children p *
   included  infected   included  included 
   n n (%)  n n (%) 
 Age at delivery (years)   0.143   0.928
  < 30 846 76 (9.0)  894 56 (6.3) 
  ≥ 30 465 31 (6.7)  440 27 (6.1) 
 Time of diagnosis   < 0.001   < 0.001
  Before or during gestation 1,242 65 (5.2)  1,266 54 (4.3) 
  At delivery or post-delivery 149 49 (32.9)  134 36 (26.9) 
 Prenatal   < 0.001   < 0.001
  Yes 1,286 84 (6.5)  1,295 73 (5.6) 
  No 101 29 (28.7)  111 20 (18.0) 
 Use of antiretroviral therapy during gestation   < 0.001   < 0.001
  Yes 1,143 48 (4.2)  1,162 33 (2.8) 
  No 261 71 (27.2)  247 60 (24.3) 
 Mode of delivery   < 0.001   < 0.001
  Vaginal 518 65 (12.5)  536  54 (10.1) 
  Non-elective caesarean section  357 32 (9.0)  308 18 (5.8) 
  Elective caesarean section 520 12 (2.3)  567 22 (3.9) 
 Viral load and CD4 count during gestation   < 0.001   < 0.001
  Yes 693 10 (1.4)  766 15 (2.0) 
  No 357 83 (23.2)  317 62 (19.6) 
 Gestational age (weeks)   < 0.001   0.515
  < 37 132 21 (15.9)  151 11 (7.3) 
  ≥ 37 672 39 (5.8)  747 44 (5.9) 
 Birth weight (grams)   < 0.001   < 0.001
  < 2,500 290 54 (18.6)  338 44 (13.0) 
  ≥ 2,500 1,172 72 (6.1)  1,123 60 (5.3) 
 Breastfeeding   < 0.001   < 0.001
  Yes 105 45 (42.9)  77 26 (33.8) 
  No 1,316 72 (5.5)  1,351 68 (5.0) 
* Chi-square test.
Succi RCM et al. S384
Cad. Saúde Pública, Rio de Janeiro, 23 Sup 3:S379-S389, 2007
tion (10.9%). Of the children with known birth 
weight, 628/2,923 (21.5%) weighed < 2,500g. The 
vertical HIV transmission rate was significantly 
higher (15.6%) among babies weighing < 2,500g 
at birth when compared with those weighing ≥ 
2,500g (5.8%).
Information about breastfeeding was ob-
tained for 2,849 children, 182 of whom received 
mother’s milk. The duration of breastfeeding var-
ied from one to 719 days (mean 112 days, me-
dian 28 days). The majority of nursing mothers 
(102/182 = 56%) were diagnosed with HIV during 
or after delivery, but 24.7% of them (45/182) were 
diagnosed before or during pregnancy. The pro-
portion of women from each region who breast-
fed their babies was: 5.7% of the women from 
the Southeastern Region, 2.6% from the South-
ern Region, 7.7% Central-Western Region, 14.4% 
from the Northeastern Region, and 2.8% from the 
Northern Region.
Use of antiretroviral therapy during child-
birth was recorded in 2,208 women (1,073 in 
2000 and 1,135 in 2001). The use of antiretroviral 
therapy during childbirth (univariate analysis) 
was found to be associated with lower mother-
to-child transmission rates of HIV in both years 
studied (4.9% in 2000 and 3.3% in 2001), when 
compared to women who did not receive this 
therapy (23.4% in 2000 and 20.2% in 2001). How-
ever, this difference was not evidenced in the 
Central-Western Region in 2000, nor in the Cen-
tral-Western and Northeastern regions in 2001. 
Almost all the newborns received AZT in the 
neonatal period (91.6% of babies born in 2000 
and 93.9% of those born in 2001); no significant 
association of such variable with vertical HIV 
transmission rates was found.
When the regimen of antiretroviral therapy 
used was analyzed, it was observed that 699 
women (363 in 2000 and 336 in 2001) did not 
receive any type of antiretroviral therapy dur-
ing gestation, 983 received AZT mono-therapy, 
431 received two drugs, and 811 received three 
or more drugs. There was a greater proportion 
of babies infected among mothers who did not 
receive any antiretroviral therapy (22.6%), com-
pared with those who received mono-therapy 
(5.4%), double therapy (2.3%), or with those 
who received three or more drugs and had the 
lowest proportion of infected babies (1.1%). 
When the rate of transmission among women 
that had received two drugs was compared 
with that of women who had received three or 
more the transmission rates were similar, but 
on comparing the infection rates among babies 
whose mothers had received mono-therapy 
with those who had received double or triple 
therapy a significant statistical difference was 
noted (Table 3).
After the data were subjected to univari-
ate analysis, the variables with no statistical 
significant association with the outcome were 
removed, and multivariate analysis was done. 
A logistic regression of all the variables studied 
was done and afterwards all variables that did 
not demonstrate a significant association with 
the outcome and had a value of p > 0.10 (moth-
er’s age, prenatal, use of antiretrovirals during 
gestation, and gestational age) were removed, 
obtaining an adjusted model depicted in Table 
4. In agreement with this adjustment, inde-
pendent factors associated with vertical HIV 
transmission were as follows: time of mother’s 
diagnosis; mode of delivery; access to viral load 
and T lymphocyte CD4 exams during gestation; 
birth weight, and breastfeeding.
Table 3 
Number of mother-child pairs included and children infected per year of birth and according to the antiretroviral regimen utilized by the mother. Brazil, 2000-
2001
 Antiretroviral regimen   Year 2000   Year 2001
  Mother-child pairs Infected children p * Mother-child pairs Infected children p *
  n n (%)  n n (%) 
    < 0.001   < 0.001
 None 363 84 (23.1)  336 74 (22.0) 
 Monotherapy 571 33 (5.8)  412 20 (4.9) 
 Dual therapy 225 4 (1.8)  206 6 (2.9) 
 Three or more drugs 303 5 (1.7)  508 4 (0.8) 
* Chi-square test.
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Discussion
The data obtained through this broad study, 
the first multicenter study that evaluated moth-
er-to-child transmission of HIV in the entire 
country, probably reflects what happened in 
the country as a whole. Notification of the HIV 
infection is not compulsory, and the notifica-
tion of HIV-infected pregnant women and ex-
posed newborns, initiated in 2000, is still incipi-
ent, having amounted to a little more than half 
the estimated cases in 2004 1. The proportional 
distribution of cases in mother-child pairs in-
cluded by region is similar to the distribution 
of cases in adults reported to the Ministry of 
Health in the years 2000 and 2001 1: 3.1% of the 
cases reported were in residents of the North-
ern Region; 8.9% in the Northeastern Region; 
57.1% in the Southeastern Region; 22.9% in the 
Southern Region; and 5.6% in the Central-West-
ern Region. Despite being quite efficient, the 
notification of AIDS cases in the country may 
not precisely represent the number of pregnant 
women infected and newborns exposed, but as 
it is available data, it is considered applicable for 
estimating the proportion of pregnant women 
in each region.
Mother-to-child transmission of HIV depends 
on various factors (maternal, viral, and fetal) and 
the rates of transmission vary in different pop-
ulations 15,16. In developed countries, as a con-
sequence of interventions in pregnant women, 
mother-to-child transmission of HIV has fallen to 
rates of less than 2%, but in developing countries 
this goal has not yet been attained.
Some groups of Brazilian authors have shown 
that, in certain health services and municipali-
ties, the adoption of strategies that increase not 
only prenatal care, but also offer of a voluntary 
HIV test, the use of antiretroviral prophylaxis 
in pregnant women and their infants, in addi-
tion to avoidance breastfeeding, have managed 
to reduce the rates of vertical HIV transmission 
9,10,11,12,13,14,17,18,19. On the other hand, the only 
multi-centric Brazilian study previously pub-
lished (evaluating data from health services in 
the São Paulo State, Brazil, documents  the fol-
low-up of 434 children exposed to HIV, born be-
tween January 1988 and April 1993) found rates 
of  vertical HIV transmission to be 16% (95%CI: 
13.0-20.0) 20.
Taking into account the findings from this 
study, it can be said that mother-to-child trans-
mission of HIV has diminished by more than 
50% in recent years, falling from a rate of 16% in 
the period from 1998 to 1993 20 to 7.1% in 2001. 
Evaluation of the two periods, done by the ref-
erence service of the city of Riberão Preto (São 
Paulo State), revealed a reduction of 44.3% in the 
transmission rate when comparing the periods 
1988-1993 and 1996-1999 21. Meanwhile, in a de-
veloped country (the United States), a compari-
son of the two periods revealed an even greater 
fall: from 18.1% in the period 1990-1992 to 1.6% 
in the period 1999-2000 22.
Even though the national mother-to-child 
transmission rate of HIV evaluated in 2001 (7.1%) 
is still elevated, this finding clearly shows that 
the strategy developed in recent years by the PN 
DST/AIDS (STD and AIDS Program) of the Min-
istry of Health has been effective. Only includ-
ing children whose HIV infection status has been 
confirmed could be considered as a potential 
cause for error in the appraisal of the HIV infec-
tion rate, but, on the other hand, the majority of 
children that had not been followed up until their 
infectious condition was defined were probably 
asymptomatic, or uninfected, and if these chil-
dren had been included in the study the trans-
mission rate observed would have been lower. 
Table 4 
Factors independently associated with mother-to-child transmission of HIV according to the fi ndings of multivariate logistic 
regression. Brazil, 2000-2001.
  Odds ratio 95%CI
 Time of mother’s diagnosis (at delivery, post-delivery/before or during pregnancy) 1.78 1.13-2.80
 Mode of delivery  
  Vaginal (vs. elective caesarean section) 1.92 1.14-3.24
  Post-labor caesarean (vs. elective caesarean section) 1.82 1.02-3.24
 Viral load and CD4 count during gestation (No/Yes) 7.08 4.26-11.79
 Birth weight (< 2,500g/≥ 2,500g) 1.79 1.19-2.69
 Breastfeeding (Yes/No) 2.49 1.55-4.02
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Other possible factors that could cause error in 
the evaluation of vertical HIV transmission rate 
should be considered: the time of antiretroviral 
therapy introduction, the quality of prenatal care, 
and the process of selecting participating health 
services.
Aside from these considerations, the access 
to health assistance is different in each region of 
the country for infected pregnant women, as well 
as for exposed children. Thus isolated facts may 
change the time in which the diagnosis of the HIV 
infection in the woman and the child is made: the 
quality of prenatal care; the utilization of differ-
ent therapeutic regimens to treat the pregnant 
woman and prophylaxis for vertical transmission 
of the virus; availability of exams to evaluate ver-
tical HIV transmission risks; and co-infections of 
the pregnant woman which may favor vertical 
HIV transmission.
Only 5.1% of the women evaluated were 18 
years or under, and in the states of the South-
eastern Region the median age was over 27 years, 
suggesting that the HIV infection is occurring af-
ter adolescence, or that younger women, when 
infected, are able to postpone, or even avoid, 
pregnancy. Other Brazilian authors found simi-
lar maternal ages in studies of mother-to-child 
HIV transmission: 16 to 43 years (median 26.1 
years) in the Rio de Janeiro State 17, 13 to 42 years 
(median 24 years) in the Mato Grosso State 18, 
and 16 to 42 years (median 27.3 years) in the 
city of Santos, São Paulo State 12. In Brazil, there 
has been a stabilizing tendency in the infection 
rates among women between 13 and 24 years 
old, with persistent growth in practically all oth-
er age groups 1 , and the data observed in this 
study reflect this increase in the rates among 
women over 27 years old.
An overwhelming majority of women in-
formed having access to prenatal care (94.% in 
2000 and 95.8% in 2001), but notwithstanding, 
the proportion of women whose HIV infection 
diagnosis was made before or during pregnancy 
was lower than the proportion of women who 
had had prenatal care (89.3% in 2000 and 90.4% 
in 2001).The fact that any number of consulta-
tions was considered “prenatal care” suggests 
that in many cases prenatal care was insufficient 
(in time and/or quality) to ensure the offer of 
HIV testing in all women and availability of the 
necessary prophylactic measures. The definition 
used in this study for prenatal care as being “any 
number of consultations by a doctor or nurse for 
follow-up during gestation”, could result in an 
underestimation of the effect of this variable on 
vertical HIV transmission rates.
The reduction of mother-to-child transmis-
sion of HIV when effective antiretroviral ther-
apy is made available has been demonstrated 
in various studies 7,20,21,23,24. Antiretroviral use 
both in treating the mother’s condition and 
preventing mother-to-child transmission, has 
been increasing in the last decade in all regions 
of the country, but the use of medication is far 
from uniform. In this study 699 women (20% 
of those for whom information was available) 
did not receive any antiretroviral therapy during 
pregnancy, again demonstrating that, although 
it can be verified that 95.2% of pregnant women 
received some kind of prenatal care, this care 
was not sufficient to guarantee access to antiret-
rovirals prophylaxis during gestation and deliv-
ery. Similarly, diagnosis of HIV infection before 
or during pregnancy (which occurred in 89.9% 
of pregnant women studied) did not guarantee 
access to this measure.
The Southeastern, Southern, and Central-
Western Regions, where the use of antiretrovi-
ral therapy during pregnancy was greatest, pre-
sented lower vertical HIV transmission rates. The 
Northern Region, which, compared to other re-
gions, had the lowest proportion of antiretroviral 
therapy use during pregnancy, also had the high-
est rates of vertical HIV transmission.
The age of the mother at the time of delivery 
(in the two years studied) and the gestational age 
(in 2001) were not found to be associated with 
a higher vertical HIV transmission rate among 
the cases evaluated using univariate analysis. 
The following variables were considered to be 
independent risk factors for mother-child HIV 
transmission in both of the years studied: late di-
agnosis of maternal infection (during delivery or 
after delivery), absence of prenatal care, no use 
of antiretroviral therapy during gestation, mode 
of delivery (vaginal delivery), no exams to follow 
the progress of the HIV infection (viral load and 
T lymphocytes CD4 count exams), birth weight 
of < 2,500g, and breastfeeding.
Caesarian section before the beginning of 
labor or rupture of membranes (elective caesar-
ian) is an intervention that has been proven to be 
useful in the prevention of vertical HIV transmis-
sion in pregnant women who have not received 
antiretroviral therapy or have only received AZT 
mono-therapy, however its utility among wom-
en who are already using highly effective anti-
retroviral therapy or who have an undetectable 
HIV viral load is still under debate 25. The rec-
ommendation of elective caesarian for 40% of 
the pregnant women in this study could be the 
reflection of two factors: the high frequency of 
caesarian section, independent of HIV infection, 
or the diffusion of the knowledge among services 
caring for HIV-positive women that this type of 
delivery is a prophylactic measure. Evaluation of 
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the risks and benefits of this measure is neces-
sary to diminish the complications associated 
with this type of delivery.
The access to exams capable of evaluating 
the evolution of HIV infection (quantification of 
viral load and T lymphocytes CD4 count) can be 
considered a benchmark of quality in the prena-
tal follow-up of pregnant women infected with 
HIV. Know-how related to familiarity with main-
tenance or control of viral replication in pregnant 
women who receive antiretroviral therapy allows 
modifying or adapting the woman’s therapy to 
reach the lowest HIV viral load at pregnancy 
term, which is known to be a fundamental factor 
in controlling virus transmission 14.
Women testing positive for HIV have a greater 
risk of premature delivery (gestation < 37 weeks) 
and for newborns with low weight (< 2,500g), and 
both variables have been found to be associated 
with mother-to-child transmission of HIV 19,34.
Despite orientation to prevent breastfeeding 
and providing formula for babies born of HIV-
infected mothers, 6.4% of children whose moth-
ers had been so informed were breastfed for up 
to 719 days. Sociocultural and economic factors 
may be responsible for the decision to breastfeed 
infants, which knowingly increases the risk of vi-
ral transmission 26.
Children followed in the Northeastern Region 
were those that proportionately were more likely 
to be breastfed, but it was not possible to estab-
lish a direct association between the proportion 
of children breastfed and the mother-to-child 
transmission of HIV rates in each region.
In spite of its limitations in respect to health 
service selection from different geographic re-
gions, the difficulties defining the infection sta-
tus in children in due time, and the difficulties in 
obtaining adequate information for all the vari-
ables evaluated, this study shows that it is neces-
sary to keep strict epidemiological surveillance 
attention on HIV-positive pregnant women and 
their HIV exposed children, not only in regard to 
case reporting, but principally in regard to mak-
ing sure that this population receives the care it 
is entitled to.
Conclusion
This study estimates that mother-to-child trans-
mission of HIV in Brazil is falling, but the different 
rates encountered in each geographic region are 
evidence of diversity in social, cultural, econom-
ic, and access to health services. HIV infection 
in children should be regarded as an important 
indicator of the quality of obstetric and neonatal 
health care assistance in the country: elevated 
rates of vertical HIV transmission indicate a lack 
of prenatal care or lack of adherence to antiretro-
viral therapy by the mother.
The necessity of identifying all the women 
infected with HIV before or during pregnancy, 
the aim of giving full access to exams that permit 
the evaluation of their immunological and viro-
logical status during pregnancy, the proper guid-
ance and use of antiretroviral therapy in order 
to control viral replication, and programming 
the type of delivery, will make possible further 
reductions in vertical HIV transmission in the 
country. The association made evident of ver-
tical HIV transmission with lower birth weight 
and breastfeeding, dramatically demonstrates 
the importance of guaranteeing quality prenatal 
care and access of children to health services so 
they can receive proper management and care, 
and be offered a substitute for mother’s milk, in 
addition to other prophylactic measures.
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Resumo
O objetivo do estudo foi descrever as taxas de trans-
missão vertical do HIV no Brasil nos anos de 2000 
e 2001, e identificar as variáveis maternas e dos re-
cém-nascidos associadas à transmissão. O estudo foi 
transversal, observacional, com dados retrospectivos 
obtidos por meio da análise de prontuários médicos 
em 63 serviços localizados nas cinco macrorregiões 
geográficas do país (vinte estados e o Distrito Federal). 
Foram consideradas, para o estudo, crianças nascidas 
de mães infectadas pelo HIV que apresentaram docu-
mentação da infecção pelo vírus antes ou durante a 
gestação, no momento da admissão para o parto ou 
nos três primeiros meses após o parto. Foram incluídas 
2.924 crianças e a taxa de transmissão vertical do HIV 
foi: 8,6% em 2000 (IC95%: 7,2-10,2) e 7,1% em 2001 
(IC95%: 5,8-8,6). As seguintes variáveis foram associa-
das com a transmissão vertical do HIV: parto cesárea 
eletiva, diagnóstico da infecção materna antes ou du-
rante a gestação, acesso a exames de quantificação da 
carga viral do HIV e contagem de linfócitos-T CD4+ 
durante a gestação, peso ao nascimento e ausência de 
aleitamento materno.
Transmissão Vertical de Doença; HIV; Cuidado Pré-
Natal
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